Po-Li Wei

24PUBLICATIONS
28CO-AUTHORS
Medical biotechnology not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 04, 2025
Correction: Leung et al. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022, 10, 377.

Wai-Hung Leung, Jing-Wen Shih, Jian-Syun Chen

|Jan 11, 2024
Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24/CTNNB1/SOX4-Centered Signaling Hub.

Jing-Wen Shih, Alexander T H Wu, Ntlotlang Mokgautsi

|Oct 28, 2023
CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.

Cheng-Chin Lee, Kuei-Yen Tsai, Ai-Wei Lee

|Jul 29, 2023
2,3,5,4'-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy.

Kuei-Yen Tsai, Po-Li Wei, Cheng-Chin Lee

|Jul 26, 2023
Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer.

Kuei-Yen Tsai, Yu-Jia Chang, Chien-Yu Huang

|Jul 14, 2023
Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.

Chien-Yu Huang, Po-Li Wei, Uyanga Batzorig

Pageof 4

Frequent Collaborators

9 joint publications

Yu-Jia Chang

4 joint publications

Jung-Chun Lin

4 joint publications

Uyanga Batzorig

3 joint publications

Chin-Sheng Hung